Lidocaine, also known as xylocaine and lignocaine, is a medication used to numb tissue in a specific area and to treat ventricular tachycardia. It can also be used for nerve blocks. Lidocaine mixed with a small amount of epinephrine is available to allow larger doses for numbing, and to make it last longer. When used as an injectable, it typically begins working within four minutes and lasts for half an hour to three hours. Lidocaine may also be applied directly to the skin for numbing.

Certificate of Analysis

• Description

  A white, crystalline powder odourless or practically odourless.

  Result

  White crystalline powder.

• Solubility

  Very soluble in water, freely soluble in chloroform and in ethanol (95%); practically insoluble in ether.

  Result

  Complies

• Identification

  (A)Infrared absorption spectrum.

  Result

  Complies

• Appearance of solution

  A 5.0 percent w/v solution in carbon dioxide-free water is clear, and colourless.

  Result

  Clear and colourless solution

• Melting Point

  Between 74°C to 79°C

  Result

  C74°C-77°Complies

• pH

  Between 4.0 to 5.5

  Result

  5.24

• Heavy Metals

  Not more than 10 ppm

  Result

  Complies

• Sulphate

  To comply test as per IP

  Result

  Complies

• 2,6.Dimethylaniline

  Not more than 100 ppm

  Result

  Complies

• Sulphate Ash

  Not more than 0.1% w/w

  Result

  Not more than 0.1% w/w

• Water

  Between 5.0 and 7.5% w/w

  Result

  6.32% w/w

• Assay

  NLT 99.0%and NMT 101.0% of C14H22N2O.HCL, on anhydrous basis.

  Result

  99.53% w/w

Note: We are leading channel partner of much API manufacturer, supplier & exporters and Pharmaceutical raw material in Colombo, Chili, Ecuador and Globally.

Material Safety Data Sheet

• Section 1 – Chemical Product

  Product Identifier

  Lidocaine Hydrochloride

  MSDS Prepared By

  R&D Department

• Section 2 – Composition / Information Of Ingredients

  Product Name

  Lidocaine Hydrochloride

  Molecular Formula

  C14H22N2OHCL.H2O

  Molecular Weight

  288.82

  CAS Number

  6108-05-0

• Section 3 – HAZARDOUS IDENTIFICATION

  General Information

  To the best of our knowledge, the Chemical / Toxicological / Physical properties of this compound have not been fully investigated. May be harmful by ingestion. Exercise appropriate precaution to prevent opportunity for inhalation and to prevent direct contact with skin and eyes.

• Section 4 – FIRST AID

  Skin Contact

  Wash off with plenty of water. Remove contaminated clothing.

  Eye Contact

  Rinse out with plenty of water.

  Inhalation

  Remove to Fresh air. Consult doctor if feeling unwell.

  Ingestion

  Remove by Emesis. Maintain Blood Pressure/ Air way. Give Oxygen if needed. Don’t induce Vomiting if unconscious. Obtain medical attention.

• Section 5 – FIRE FIGHTING MEASURES

  Flash Point

  N/A

  Flammable Limits

  N/A

  Auto-ingestion Temperature

  N/A

• Section 6 – ACCIDENT RELEASE MEASURES

  Small Spills

  Sweep up & place in suitable clean, dry containers for reclamation / later disposal.

  Large Spills

  Do not allow to enter drains, sewers, or watercourses. Absorb spillages onto sand, earth, or any suitable absorbent material. Transfer to a container for disposal. Wash the spillage area with water, and flush to a sewer services by a wastewater treatment facility.

• Section 7 – HANDLING AND STORAGE

  Handling

  No further requirements.

  Storage

  Keep container tightly closed.

  Storage Temperature

  At + 15º C to + 25º

• Section 8 – EXPOSURE CONTROLS / PERSONAL PROTECTION

  Personal Protective Equipment

  Respirators

  Use NIOSH/MSHA approved respirator based on contamination level found in work place & must not exceed working limits of the respirator.

  Protective Clothing

  Impervious gloves and apron.

  Eye Protection

  Splash proof safety goggles/ face shield.

  Other Protective Equipment/span>

  Eyewash station and safety shower in work area.

• Section 9 – PHYSICAL AND CHEMICAL PROPERITIES

  Form

  Powder

  Colour

  White

  Odour

  Odourless

  Melting Point

  74 -187 ° C

  Vapor Pressure (mm Hg)

  N/A

  Solubility (Water)

  Readily soluble

  Vapor Density (Air = 1)

  N/A

• Section 10 – STABILITY AND REACTIVITY

  Chemical Stability

  Stable

  Incompatible Materials

  N/A

  Hazardous Decomposition Product(s)

  Vapours and gases.

• Section 11 – TOXICOLOGICAL INFORMATION

  No data available.

• Section 12 – ECOLOGICAL INFORMATION

  No data available.

• Section 13 – DISPOSAL CONSIDERATION

  General Information

  Disposal should be in accordance with local, state, or national legislation.

  Disposal Method

  Discarded product is not a hazardous waste.

  Container Disposal

  Empty container contains product residue. Observe all hazard precautions.

• Section 14 – TRANSPORT INFORMATION

  General Information

  No subject to transport regulation. Safe for transportation by Airs as well as sea.

• Section 15 – REGULATORY INFORMATION

  Labelling according to EC directives

  SARA title III information

  No data

  Federal regulatory information

  No data

  State regulatory information

  No data

• Section 16 – OTHER INFORMATION

  Global Pharma provides information contained herein in good faith but makes no representation as to its comprehensives or accuracy. This document is intended only as a guide to the appropriate precautionary handling of the material by a properly trained person using this product.

  Individuals receiving the information must exercise their independent judgment in determining its appropriateness for a particular purpose.

  GLOBAL PHARMA MAKES NO REPRESENTATIONS OR WARRANTIES, EITHER EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTIES OR MERCHANTABILITY, FITNESS FOR A PARTICULER PURPOSE WITH RESPECT TO THE INFORMATION SET FORTH HEREIN OR THE PRODUCT WHICH THE INFORMATION REEFERS. GLOBAL PHARMA WILL NOT BE RESPONSIBLE FOR DAMAGES RESULTING FROM USE OF RELIANCE UPON THIS INFORMATION.